Liver and Biliary Tract

Dysregulated hepatic expression of glucose transporters in chronic disease : contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptake

Published Online:https://doi.org/10.1152/ajpgi.00377.2013

Insulin resistance is common in patients with chronic liver disease (CLD). Serum levels of soluble vascular adhesion protein-1 (VAP-1) are also increased in these patients. The amine oxidase activity of VAP-1 stimulates glucose uptake via translocation of transporters to the cell membrane in adipocytes and smooth muscle cells. We aimed to document human hepatocellular expression of glucose transporters (GLUTs) and to determine if VAP-1 activity influences receptor expression and hepatic glucose uptake. Quantitative PCR and immunocytochemistry were used to study human liver tissue and cultured cells. We also used tissue slices from humans and VAP-1-deficient mice to assay glucose uptake and measure hepatocellular responses to stimulation. We report upregulation of GLUT1, -3, -5, -6, -7, -8, -9, -10, -11, -12, and -13 in CLD. VAP-1 expression and enzyme activity increased in disease, and provision of substrate to hepatic VAP-1 drives hepatic glucose uptake. This effect was sensitive to inhibition of VAP-1 and could be recapitulated by H2O2. VAP-1 activity also altered expression and subcellular localization of GLUT2, -4, -9, -10, and -13. Therefore, we show, for the first time, alterations in hepatocellular expression of glucose and fructose transporters in CLD and provide evidence that the semicarbazide-sensitive amine oxidase activity of VAP-1 modifies hepatic glucose homeostasis and may contribute to patterns of GLUT expression in chronic disease.

REFERENCES

  • 1. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, Zorzano A, Marti L. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47: 429–438, 2004.
    Crossref | PubMed | Web of Science | Google Scholar
  • 2. Balkau B, Kahn HS, Courbon D, Eschwege E, Ducimetiere P. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study. Diabetes Care 24: 843–849, 2001.
    Crossref | PubMed | Web of Science | Google Scholar
  • 3. Bhogal RH, Hodson J, Bartlett DC, Weston CJ, Curbishley SM, Haughton E, Williams KT, Reynolds GM, Newsome PN, Adams DH, Afford SC. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLos One 6: e18222, 2011.
    Crossref | PubMed | Web of Science | Google Scholar
  • 4. Bonaiuto E, Lunelli M, Scarpa M, Vettor R, Milan G, Di Paolo ML. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme. Biochimie 92: 858–868, 2010.
    Crossref | PubMed | Web of Science | Google Scholar
  • 5. Bour S, Caspar-Bauguil S, Iffiu-Soltesz Z, Nibbelink M, Cousin B, Miiluniemi M, Salmi M, Stolen C, Jalkanen S, Casteilla L, Penicaud L, Valet P, Carpene C. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition. Am J Pathol 174: 1075–1083, 2009.
    Crossref | PubMed | Web of Science | Google Scholar
  • 6. Bril F, Lomonaco R, Orsak B, Ortiz-Lopez C, Webb A, Tio F, Hecht J, Cusi K. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology 59: 2178–2187, 2014.
    Crossref | PubMed | Web of Science | Google Scholar
  • 7. Carayannopoulos MO, Chi MM, Cui Y, Pingsterhaus JM, McKnight RA, Mueckler M, Devaskar SU, Moley KH. GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci USA 97: 7313–7318, 2000.
    Crossref | PubMed | Web of Science | Google Scholar
  • 8. Claridge LC, Westerlund N, Haughton EL, Weston CJ, Lalor PF, Smith DJ, Day CP, Adams DH. Vascular adhesion protein-1 (VAP-1) is a novel biomarker and a potential anti-inflammatory and anti-fibrotic target in nonalcoholic fatty liver disease (NAFLD) (Abstract). Hepatology 50: 783A–784A, 2009.
    Web of Science | Google Scholar
  • 9. Dunkel P, Gelain A, Barlocco D, Haider N, Gyires K, Sperlagh B, Magyar K, Maccioni E, Fadda A, Matyus P. Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Curr Med Chem 15: 1827–1839, 2008.
    Crossref | PubMed | Web of Science | Google Scholar
  • 10. El Hadri K, Moldes M, Mercier N, Andreani M, Pairault J, Feve B. Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arterioscler Thromb Vasc Biol 22: 89–94, 2002.
    Crossref | PubMed | Web of Science | Google Scholar
  • 11. Enrique-Tarancon G, Castan I, Morin N, Marti L, Abella A, Camps M, Casamitjana R, Palacin M, Testar X, Degerman E, Carpene C, Zorzano A. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells. Biochem J 350: 171–180, 2000.
    Crossref | PubMed | Web of Science | Google Scholar
  • 12. Enrique-Tarancon G, Marti L, Morin N, Lizcano JM, Unzeta M, Sevilla L, Camps M, Palacin M, Testar X, Carpene C, Zorzano A. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J Biol Chem 273: 8025–8032, 1998.
    Crossref | PubMed | Web of Science | Google Scholar
  • 14. Erice E, Llop E, Berzigotti A, Abraldes JG, Conget I, Seijo S, Reverter E, Albillos A, Bosch J, Garcia-Pagan JC. Insulin resistance in patients with cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol 302: G1458–G1465, 2012.
    Link | Web of Science | Google Scholar
  • 15. Evans SA, Doblado M, Chi MM, Corbett JA, Moley KH. Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells. Endocrinology 150: 5302–5310, 2009.
    Crossref | PubMed | Web of Science | Google Scholar
  • 16. Giordano D, Corrado F, Santamaria A, Quattrone S, Pintaudi B, Di Benedetto A, D'Anna R. Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. Menopause 18: 102–104, 2011.
    Crossref | PubMed | Web of Science | Google Scholar
  • 17. Gonzalez-Rodriguez A, Nevado C, Escriva F, Sesti G, Rondinone CM, Benito M, Valverde AM. PTP1B deficiency increases glucose uptake in neonatal hepatocytes: involvement of IRA/GLUT2 complexes. Am J Physiol Gastrointest Liver Physiol 295: G338–G347, 2008.
    Link | Web of Science | Google Scholar
  • 18. Gres S, Bour S, Valet P, Carpene C. Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter. J Physiol Biochem 68: 651–662, 2012.
    Crossref | PubMed | Web of Science | Google Scholar
  • 19. Guyot C, Combe C, Balabaud C, Bioulac-Sage P, Desmouliere A. Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J Hepatol 46: 142–150, 2007.
    Crossref | PubMed | Web of Science | Google Scholar
  • 20. Hoffler U, Hobbie K, Wilson R, Bai R, Rahman A, Malarkey D, Travlos G, Ghanayem BI. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine 36: 311–325, 2009.
    Crossref | PubMed | Web of Science | Google Scholar
  • 21. Holecek M, Sprongl L, Tichy M, Pecka M. Leucine metabolism in rat liver after a bolus injection of endotoxin. Metabolism 47: 681–685, 1998.
    Crossref | PubMed | Web of Science | Google Scholar
  • 22. Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 136: 705–714, 2009.
    Crossref | PubMed | Web of Science | Google Scholar
  • 23. Humphreys EH, Williams KT, Adams DH, Afford SC. Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand. PLos One 5: e14037, 2010.
    Crossref | PubMed | Web of Science | Google Scholar
  • 24. Karim S, Liaskou E, Hadley S, Youster J, Faint J, Adams DH, Lalor PF. An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells. Toxicol Sci 132: 131–141, 2013.
    Crossref | PubMed | Web of Science | Google Scholar
  • 26. Kasai D, Adachi T, Deng L, Nagano-Fujii M, Sada K, Ikeda M, Kato N, Ide YH, Shoji I, Hotta H. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol 50: 883–894, 2009.
    Crossref | PubMed | Web of Science | Google Scholar
  • 27. Keembiyehetty C, Augustin R, Carayannopoulos MO, Steer S, Manolescu A, Cheeseman CI, Moley KH. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol 20: 686–697, 2006.
    Crossref | PubMed | Google Scholar
  • 28. Kim E, Seok HH, Lee SY, Lee DR, Moon J, Yoon TK, Lee WS, Lee KA. Correlation between expression of glucose transporters in granulosa cells and oocyte quality in women with polycystic ovary syndrome. Endocrinol Metab (Seoul) 29: 40–47, 2014.
    Crossref | PubMed | Google Scholar
  • 29. Kim GH, Park EC, Yun SH, Hong Y, Lee DG, Shin EY, Jung J, Kim YH, Lee KB, Jang IS, Lee ZW, Chung YH, Choi JS, Cheong C, Kim S, Kim SI. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver. Proteomics 13: 1164–1179, 2013.
    Crossref | PubMed | Web of Science | Google Scholar
  • 30. Koskinen K, Vainio PJ, Smith DJ, Pihlavisto M, Yla-Herttuala S, Jalkanen S, Salmi M. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood 103: 3388–3395, 2004.
    Crossref | PubMed | Web of Science | Google Scholar
  • 31. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135: 122–130, 2008.
    Crossref | PubMed | Web of Science | Google Scholar
  • 32. Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R, Yki-Jarvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293: E1709–E1715, 2007.
    Link | Web of Science | Google Scholar
  • 33. Kouidhi S, Berrhouma R, Rouissi K, Jarboui S, Clerget-Froidevaux MS, Seugnet I, Bchir F, Demeneix B, Guissouma H, Elgaaied AB. Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes. Acta Diabetol 50: 227–232, 2013.
    Crossref | PubMed | Web of Science | Google Scholar
  • 34. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol 161: 1549–1557, 1998.
    PubMed | Web of Science | Google Scholar
  • 35. Kurkijarvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 119: 1096–1103, 2000.
    Crossref | PubMed | Web of Science | Google Scholar
  • 37. Lalor PF, Curbishley SM, Adams DH. Identifying homing interactions in T-cell traffic in human disease. Methods Mol Biol 616: 231–252, 2010.
    Crossref | PubMed | Google Scholar
  • 38. Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 169: 983–992, 2002.
    Crossref | PubMed | Web of Science | Google Scholar
  • 39. Lalor PF, Sun PJ, Weston CJ, Martin-Santos A, Wakelam MJ, Adams DH. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-κB-dependent increase in lymphocyte adhesion. Hepatology 45: 465–474, 2007.
    Crossref | PubMed | Web of Science | Google Scholar
  • 41. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 47: 142–156, 2007.
    Crossref | PubMed | Web of Science | Google Scholar
  • 42. Lee YC, Huang HY, Chang CJ, Cheng CH, Chen YT. Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. Hum Mol Genet 19: 3721–3733, 2010.
    Crossref | PubMed | Web of Science | Google Scholar
  • 43. Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH. Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity. Hepatology 53: 661–672, 2011.
    Crossref | PubMed | Web of Science | Google Scholar
  • 44. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔCT) method. Methods 25: 402–408, 2001.
    Crossref | PubMed | Web of Science | Google Scholar
  • 45. McVie-Wylie AJ, Lamson DR, Chen YT. Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. Genomics 72: 113–117, 2001.
    Crossref | PubMed | Web of Science | Google Scholar
  • 46. Meszaros Z, Szombathy T, Raimondi L, Karadi I, Romics L, Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 48: 113–117, 1999.
    Crossref | PubMed | Web of Science | Google Scholar
  • 47. Miles A, Liaskou E, Eksteen B, Lalor PF, Adams DH. CCL25 and CCL28 promote α4β7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow. Am J Physiol Gastrointest Liver Physiol 294: G1257–G1267, 2008.
    Link | Web of Science | Google Scholar
  • 48. Nanji AA, Fogt F, Griniuviene B. Alterations in glucose transporter proteins in alcoholic liver disease in the rat. Am J Pathol 146: 329–334, 1995.
    PubMed | Web of Science | Google Scholar
  • 49. Nielsen MF, Caumo A, Aagaard NK, Chandramouli V, Schumann WC, Landau BR, Schmitz O, Vilstrup H. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol 288: G1135–G1143, 2005.
    Link | Web of Science | Google Scholar
  • 50. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 19: 379–406, 1999.
    Crossref | PubMed | Web of Science | Google Scholar
  • 51. Purcell SH, Aerni-Flessner LB, Willcockson AR, Diggs-Andrews KA, Fisher SJ, Moley KH. Improved insulin sensitivity by GLUT12 overexpression in mice. Diabetes 60: 1478–1482, 2011.
    Crossref | PubMed | Web of Science | Google Scholar
  • 52. Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, Jalkanen S, Salomaa V. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol 161: 2255–2262, 2002.
    Crossref | PubMed | Web of Science | Google Scholar
  • 53. Schurmann A, Axer H, Scheepers A, Doege H, Joost HG. The glucose transport facilitator GLUT8 is predominantly associated with the acrosomal region of mature spermatozoa. Cell Tissue Res 307: 237–242, 2002.
    Crossref | PubMed | Web of Science | Google Scholar
  • 54. Souza-Mello V, Gregorio BM, Cardoso-de-Lemos FS, de Carvalho L, Aguila MB, Mandarim-de-Lacerda CA. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin Sci (Lond) 119: 239–250, 2010.
    Crossref | PubMed | Web of Science | Google Scholar
  • 55. Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. FASEB J 18: 702–704, 2004.
    Crossref | PubMed | Web of Science | Google Scholar
  • 57. Taguchi K, Yamanaka-Okumura H, Mizuno A, Nakamura T, Shimada M, Doi T, Takeda E. Insulin resistance as early sign of hepatic dysfunction in liver cirrhosis. J Med Invest 61: 180–189, 2014.
    Crossref | PubMed | Google Scholar
  • 58. Weston CJ, Adams DH. Hepatic consequences of vascular adhesion protein-1 expression. J Neural Transm 118: 1055–1064, 2011.
    Crossref | PubMed | Web of Science | Google Scholar
  • 59. Wu T, Pan T, Zheng Z, Chen T, Pan Y. [Relationship between Glut-1, Glut-3 expression and fluorodeoxyglucose uptake in NSCLC and benign pulmonary lesion.]. Zhongguo Fei Ai Za Zhi 11: 555–558, 2008.
    PubMed | Google Scholar
  • 60. Yamanaka H, Genjida K, Yokota K, Taketani Y, Morita K, Miyamoto KI, Miyake H, Tashiro S, Takeda E. Daily pattern of energy metabolism in cirrhosis. Nutrition 15: 749–754, 1999.
    Crossref | PubMed | Web of Science | Google Scholar
  • 61. Zimmerman RL, Fogt F, Burke M, Murakata LA. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma. Oncol Rep 9: 689–692, 2002.
    PubMed | Web of Science | Google Scholar
  • 62. Zorzano A, Abella A, Marti L, Carpene C, Palacin M, Testar X. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim Biophys Acta 1647: 3–9, 2003.
    Crossref | PubMed | Web of Science | Google Scholar